Ionic Capital Management’s Strata Critical Medical SRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
– Sell
-203,313
Closed -$527K – 200
2023
Q3
$527K Buy
+203,313
New +$714K 0.13% 111
2023
Q1
– Sell
-152,660
Closed -$622K – 345
2022
Q4
$547K Buy
152,660
+73,408
+93% +$314K 0.13% 139
2022
Q3
$319K Buy
79,252
+58,726
+286% +$302K 0.04% 241
2022
Q2
$92K Buy
+20,526
New +$148K 0.01% 329

Other funds holding SRTA

Ionic Capital Management's SRTA Position: Q4 2023 in Review

Ionic Capital Management sold out of Strata Critical Medical (SRTA) in Q4 2023, closing a stake of 203,313 shares — an estimated $527K sold.

Ionic Capital Management first reported a position in SRTA in Q2 2022 and held it in 4 quarters. The position peaked at $547K in Q4 2022. 102 funds tracked by Wall St. Rank hold SRTA as of Q4 2023.

  • Ionic Capital Management reported no remaining Strata Critical Medical position as of Q4 2023 after selling out during the quarter.
  • Ionic Capital Management sold 203,313 Strata Critical Medical shares in Q4 2023, an estimated $527K.
  • Ionic Capital Management first reported a position in Strata Critical Medical in Q2 2022 and held it in 4 quarters.
  • Ionic Capital Management's Strata Critical Medical position peaked at $547K in Q4 2022.
  • 102 funds tracked by Wall St. Rank held Strata Critical Medical as of Q4 2023.

Based on Ionic Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.